KWF
Validation of Biomarkers 2027
Pre-proposal deadline: 20 October 2026, 12:00 noon. Full proposal deadline: 23 February 2027, 12:00 noon.
Last verified:
Details
| Funder | KWF |
| Budget | €0.8M–€2M per proposal |
| Deadline | 20 October 2026 |
| Duration | 2–5 years |
| Consortium | Required — minimum 4 participating parties (may include private partners) |
| Application | 2-stage: pre-proposal (opens 25 Aug 2026, closes 20 Oct 2026) → full proposal (opens 15 Dec 2026, closes 23 Feb 2027), followed by interviews (May 2027) and funding decision (June 2027) |
| TRL | 5-6 |
| Frequency | Annual |
| Eligible countries | NL |
Eligibility & scope
Clinical validation of known oncology biomarkers (TRL 5/6) for use in daily clinical practice. Requires a multidisciplinary consortium of ≥4 parties including biostatistician and HTA expert; patient involvement is mandatory. AI-component projects must engage the AI4HEALTH consortium. Public-private collaborations encouraged with co-funding. Proposals submitted via KWF GMS; Dutch institutions only.
Related on Grantsby
- KWF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
More from KWF
KWF Proof of Concept 2026-PoC-2
Deadline: 2 Jun 2026Up to €150,000 incl. VATProof Of Concept 2026-2
Deadline: 2 Jun 2026KWF Proof of Concept (PoC) Programme – Call 2026-PoC-2
Deadline: 2 Jun 2026Up to €150,000 incl. VATINTER-LOCAL: International Call for Better Local Treatment of Rare/Hard-to-Treat Cancers
Deadline: 18 Jun 2026International consortium funding (5 European charities)INTER-LOCAL: International Funding Call for Local Treatment Strategies in Rare and Hard-to-Treat Cancers
Deadline: 18 Jun 2026
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free